Francine Camacho

Francine Camacho

Auto-generated profile, based on publicly available information

Francine Camacho

Viome,Inc. Viome Life Sciences, Bothell/Bellevue WA 98011/98004. Viome Bioinformatics, New York, NY 10018, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in Science
Verified
Journal Article
Closed access
PDF file
YSYuki Sugimoto
Yuki Sugimoto
FCFrancine R. Camacho
Francine R. Camacho
SWShuo Wang
Shuo Wang
PCPranatchareeya Chankhamjon
Pranatchareeya Chankhamjon
AOArman Odabas
Arman Odabas
MDMohamed S. Donia
Mohamed S. Donia
Prospecting for drugs in the microbiome: The microbiome is an important source of natural products that can profoundly influence health and disease in the host. Sugimoto et al. constructed a modular, probabilistic strategy called MetaBGC to uncover biosynthetic gene clusters (BGCs) in human microbiome samples (see the Perspective by Henke and Clardy). The authors found geographic and strain-specific distributions of BGCs. By zeroing in on two type II aromatic polyketides, the native organisms were identified, the BGCs were reconstructed in Streptomyces , and the products were characterized. When expressed in Bacillus subtilis , the products resembled currently used anticancer drugs and antibiotics. These polyketides were not cytotoxic but had inhibitory activity against oral Gram-positive bacteria, which may reflect the niche and ecology of the originating organisms. Science , this issue p. eaax9176 ; see also p. 1309

8 December 2021 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
GBGuru Banavar
Guru Banavar
OOOyetunji Ogundijo
Oyetunji Ogundijo
RTRyan Toma
Ryan Toma
SRSathyapriya Rajagopal
Sathyapriya Rajagopal
YLYen Kai Lim
Yen Kai Lim
Chamindie K. PunyadeeraChamindie K. Punyadeera
Chamindie K. Punyadeera
Despite advances in cancer treatment, the 5-year mortality rate for oral cancers (OC) is 40%, mainly due to the lack of early diagnostics. To advance early diagnostics for high-risk and average-risk populations, we developed and evaluated machine-learning (ML) classifiers using metatranscriptomic data from saliva samples (n = 433) collected from oral premalignant disorders (OPMD), OC patients (n = 71) and normal controls (n = 171). Our diagnostic classifiers yielded a receiver operating characteristics (ROC) area under the curve (AUC) up to 0.9, sensitivity up to 83% (92.3% for stage 1 cancer) and specificity up to 97.9%. Our metatranscriptomic signature incorporates both taxonomic and functional microbiome features, and reveals a number of taxa and functional pathways associated with OC. We demonstrate the potential clinical utility of an AI/ML model for diagnosing OC early, opening a new era of non-invasive diagnostics, enabling early intervention and improved patient outcomes.

10 August 2020 in BioTechniques
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
NDNathan Duval
Nathan Duval
BPBenjamin Pelle
Benjamin Pelle
MPMatthew M Parks
Matthew M Parks
VGVishakh Gopu
Vishakh Gopu
MVMomchilo Vuyisich
Momchilo Vuyisich
To prevent and treat chronic diseases, including cancer, a global application of systems biology is needed. We report here a whole blood transcriptome test that needs only 50 μl of capillary (finge... METHOD SUMMARY This report describes an important improvement to whole blood transcriptome analysis. While current methods are complicated and expensive, the method reported here includes at-home s...

9 January 2023 in BioTechniques
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
YCYing Cai
Ying Cai
OOOyetunji Ogundijo
Oyetunji Ogundijo
LHLan Hu
Lan Hu
SGStephanie Gline
Stephanie Gline
MVMomchilo Vuyisich
Momchilo Vuyisich
The authors report here the development of a high-throughput, automated, inexpensive and clinically validated saliva metatranscriptome test that requires less than 100 μl of saliva. RNA is preserve... Method summary This paper introduces a novel method for the preservation and metatranscriptomic analysis of low volumes of saliva. The method involves mixing saliva with a preservative at the time ...

19 August 2020 in Research Square
Verified
Preprint
Open access
PDF file
GBGuru Banavar
Guru Banavar
OOOyetunji Ogundijo
Oyetunji Ogundijo
RTRyan Toma
Ryan Toma
SRSathyapriya Rajagopal
Sathyapriya Rajagopal
YLYenkai Lim
Yenkai Lim
Chamindie K. PunyadeeraChamindie K. Punyadeera
Chamindie K. Punyadeera
Despite advances in cancer treatment, the five-year mortality rate for oral cancers (OC) is 40%, mainly due to the lack of early diagnostics. To advance early diagnostics for high-risk and average-risk populations, we developed and evaluated machine-learning (ML) classifiers using metatranscriptomic data from saliva samples (n=433) collected from oral premalignant disorders (OPMD), OC patients (n=71) and normal controls (n=171). Our diagnostic classifiers yielded a receiver operating characteristics (ROC) area under the curve (AUC) up to 0.9, sensitivity up to 83% (92.3% for stage 1 cancer) and specificity up to 97.9%. Our metatranscriptomic signature incorporates both taxonomic and functional microbiome features, and reveals a number of previously known and novel taxa and functional pathways associated with OC. For the first time, we demonstrate the potential clinical utility of an AI/ML model for diagnosing OC early, opening a new era of non-invasive diagnostics, enabling early intervention and improved patient outcomes.